NCT05898646 2026-03-30Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA TrialMayo ClinicPhase 2 Recruiting96 enrolled
NCT06192979 2026-03-09Optimize First-line Treatment for AL Amyloidosis With t (11; 14)Peking University People's HospitalPhase NA Recruiting41 enrolled
NCT03283917 2026-02-27Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisM.D. Anderson Cancer CenterPhase 1 Active not recruiting21 enrolled